Bank of Montreal
YMAB

Bank of Montreal’s Y-mAbs Therapeutics YMAB Stock Holding History

Bank of Montreal’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-945
Closed -$27K – 4990
2021
Q1 		$27K Sell
945
-3,861
-80% -$158K ﹤0.01% 3950
2020
Q4 		$249K Buy
4,806
+3,336
+227% +$154K ﹤0.01% 3104
2020
Q3 		$56K Sell
1,470
-1,007
-41% -$40.1K ﹤0.01% 3382
2020
Q2 		$100K Buy
2,477
+2,370
+2,215% +$89.6K ﹤0.01% 3089
2020
Q1 		$3K Sell
107
-2,877
-96% -$83.5K ﹤0.01% 3804
2019
Q4 		$93K Buy
2,984
+1,196
+67% +$35.4K ﹤0.01% 3538
2019
Q3 		$47K Buy
1,788
+79
+5% +$2.02K ﹤0.01% 3654
2019
Q2 		$39K Buy
+1,709
New +$39.2K ﹤0.01% 3815

Other funds holding YMAB

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Montreal's YMAB Position: Q2 2021 in Review

Bank of Montreal sold out of Y-mAbs Therapeutics (YMAB) in Q2 2021, closing a stake of 945 shares — an estimated $27K sold.

Bank of Montreal first reported a position in YMAB in Q2 2019 and held it in 8 quarters. The position peaked at $249K in Q4 2020. 100 funds tracked by Wall St. Rank hold YMAB as of Q2 2021.

  • Bank of Montreal reported no remaining Y-mAbs Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 945 Y-mAbs Therapeutics shares in Q2 2021, an estimated $27K.
  • Bank of Montreal first reported a position in Y-mAbs Therapeutics in Q2 2019 and held it in 8 quarters.
  • Bank of Montreal's Y-mAbs Therapeutics position peaked at $249K in Q4 2020.
  • 100 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.